Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: Implication for cyclosporine metabolism

Drug Metabolism and Disposition

Volumn 27, Issue 12, 1999, Pages 1505-1511

  Jäger, Walter ^a   Correia, Maria Almira ^b,c   Bornheim, Lester M ^b,c   Mahnke, Axel ^d   Hanstein, Walter G ^d   Xue, Linlong ^b,c   Benet, Leslie Z ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ETHINYLESTRADIOL; IMMUNOGLOBULIN G; MESSENGER RNA; MIDAZOLAM;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ESCHERICHIA COLI; FEMALE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYCLOSPORINE; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ETHINYL ESTRADIOL; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; RATS;

EID: 0344241102     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bertault-Peres P, Bonfils C, Fabre G, Just S, Cano JP and Maurel P (1987) Metabolism of cyclosporin A: II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metab Dispos 15:391-398.
2. Bornheim LM and Correia MA (1989a) Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol. Mol Pharmacol 36:377-383.
3. Bomheim LM and Correia MA (1989b) Effect of cannabidiol on cytochrome P-450 isoenzymes. Biochem Pharmacol 38:2789-2794.
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Combalbert J, Fabre I. Fabre G, Dalet I, Derancourt J, Cano JP and Maurel P (1989) Metabolism of cyclosporine A: IV Purification and identification of rifampin-inducible human liver cytochrome P-450 (cyclosporine A oxidase) as a product of P-450 IIIA gene subfamily. Drug Metab Dispos 17:197-207.
6. Fahr A (1993) Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 24:472-495.
7. Gascon MP and Dayer P (1991) In vitro forecasting of drugs which may interfere with the biotransformation of midazolam. Ear J Clin Pharmacol 41:573-578.
8. Gonzalez FJ, Nebert DW, Hardwick JP and Kasper CB (1985) Complete cDNA and protein sequence of a pregnenolone 16α-carbonitrile-induced cytochrome P-450. J Biol Chem 260: 7435-7441.
9. Gonzalez FJ, Song BJ and Hardwick JP (1986) Pregnenolone 16α-carbonitrile-inducible P-450 gene family: Gene conversion and differential regulation. Mol Cell Biol 6:2969-2976.
10. Halpert JR, Guengerich FP, Bend JR and Correia MA (1994) Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol 125:163-175.
11. Kirita S and Matsubara T (1993) cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch Biochem Biophys 307:253-258.
12. Kolars JC, Stetson PL, Rush BD, Ruwart MJ, Schmiedlin-Ren P, Duell EA, Voorhees JJ and Watkins PB (1992) Cyclosporine metabolism by P450IIIA in rat enterocytes - another determinant of oral bioavailability? Transplantation 53:596-602.
13. Komori M and Oda Y (1994) A major glucocorticoid-inducible P450 in rat liver liver is not P450 3A1. J Biochem 116:114-120.
14. Kronbach T, Fischer V and Meyer DA (1988) Cyclosporine metabolism in human liver: Identification of a cytochrome P450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 43:630-635.
15. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG and Nef P (1997) Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3 A subfamily in rat liver. Arch Biochem Biophys 337:62-68.
17. Maurer G, Loosli HR, Schreier E and Keller B (1984) Disposition of cyclosporine in several animal species and man: I. Structural elucidation of its metabolites. Drug Metab Dispos 12:120-127.
18. Nagata K, Murayama N, Miyata M, Shimada M, Urahashi A, Yamazoe Y and Kato R (1996) Isolation and characterization of a new rat P450 (CYP3AI8) cDNA encoding P450(6)beta-2 catalyzing testosterone 6 beta- and 16 alpha-hydroxylation. Pharmacogenetics 6:103-111.
19. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes II. solubilization, purification, and properties. J Biol Chem 239:2370-2378.
20. Pichard L. Fabre I. Fabre G, Domergue J, Aubert BS, Mourad G and Maurel P (1990) Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 8:595-606.
21. Prueksaritanont T. Correia MA, Rettie AE, Swinney DC, Thomas PE and Benet LZ (1993) Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzymes(s) other than cytochromes P-450 3A. Drug Metab Dispos 21:730-737.
22. Robertson GR, Fanell GC and Liddle C (1998) Sexually dimorphic expression of rat CYP3A9 and CYP3AI8 genes is regulated by growth hormone. Biochem Biophys Res Commun 242:57-60.
23. Strotkamp D. Roos PH and Hanstein WG (1995) Possible existence of a CYP3A protein in liver microsomes from female rats. Biochem Biophys Acta 1260:341-344.
24. Wandel C, Böcker RH, Böhrer H, deVries JX, Hofmann W, Walter K, Kleingeist B, Neff S, Ding R. Walter-Sack I and Martin E (1998) Relationship between hepatic cytochrome P450 3A content and activity and the disposition of midazolam administered orally. Drug Metab Dispos 26:110-114.
25. Wang H, Kawashima H and Strobel HW (1996) cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 221:157-162.
26. Wang H and Strobel HW (1997) Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys 344:365-372.
27. Wang HF, Dick R, Yin H, Licad-Coles E, Kroetz D, Szklarz G, Halpert JR and Correia MA (1998) Structure-function relationships of human liver cytochromes P450 3A: Aflatoxin B1 metabolism as a probe. Biochemistry 37:12536-12545.
28. White IH and Muller-Eberhard U (1977) Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol. Biochem J 166:57-64.